Neoadjuvant chemotherapy endows CD9 with prognostic value that differs between tumor and stromal areas in patients with pancreatic cancer

BACKGROUND: The selective pressure imposed by chemotherapy creates a barrier to tumor eradication and an opportunity for metastasis and recurrence. As a newly discovered stemness marker of pancreatic ductal adenocarcinoma (PDAC), the impact of CD9 on tumor progression and patient's prognosis re...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xuan, Zhang, Wu‐Hu, Gao, He‐Li, Li, Tian‐Jiao, Xu, Hua‐Xiang, Li, Hao, Li, Peng‐Cheng, Wang, Xu, Yu, Xian‐Jun, Wang, Wen‐Quan, Liu, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279986/
https://www.ncbi.nlm.nih.gov/pubmed/35622458
http://dx.doi.org/10.1002/jcla.24517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279986/
https://www.ncbi.nlm.nih.gov/pubmed/35622458
http://dx.doi.org/10.1002/jcla.24517

Ejemplares similares